Search results
Apr 14, 2021 · BRASH syndrome is a life-threatening condition caused by hyperkalaemia and AV-nodal blocking medications. Learn how to recognize, manage, and prevent this syndrome with fluid resuscitation, calcium, diuretics, and adrenaline.
Feb 15, 2016 · BRASH syndrome refers to a vicious cycle which may occur when a patient taking AV node blockers develops renal failure and hyperkalemia. This leads to a spiral of worsening hyperkalemia, renal failure, and bradycardic shock.
Mar 27, 2023 · The BRASH acronym describes a syndrome involving bradycardia, renal failure, AV nodal blockade, shock, and hyperkalemia. The synergism between AV nodal blocking medications and hyperkalemia results in a life-threatening condition that requires prompt recognition and management.
Aug 1, 2020 · BRASH syndrome is initiated by synergistic bradycardia due to the combination of hyperkalemia and medications that block the atrioventricular (AV) node. The most common precipitant is hypovolemia or medications promoting hyperkalemia or renal injury.
Jun 26, 2021 · BRASH syndrome is a life-threatening condition caused by bradycardia, renal failure, AV nodal blockers, shock, and hyperkalemia. Learn how to recognize, diagnose, and manage this syndrome with EMCrit's rapid reference, podcast, and case discussion.
Jun 18, 2020 · BRASH syndrome is initiated by synergistic bradycardia due to the combination of hyperkalemia and medications that block the atrioventricular (AV) node. The most common precipitant is hypovolemia or medications promoting hyperkalemia or renal injury.
INTRODUCTION: BRASH syndrome is a newly recognized clinical entity characterized by bradycardia, renal failure, AV blockade, shock, and hyperkalemia. Patients with BRASH syndrome often have severe bradycardia that is refractory to antidotes and chronotropic medications.
